Serena Zacchigna

Dr. Serena Zacchigna

Cardiovascular Biology Laboratory, International Centre for Genetic Engineering and Biotechnology, ICGEB, Trieste, Italy

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2012 in Nature
Verified
Journal Article
Closed access
AEAna Eulalio
Ana Eulalio
MMMiguel Mano
Miguel Mano
MFMatteo Dal Ferro
Matteo Dal Ferro
LZLorena Zentilin
Lorena Zentilin
GSGianfranco Sinagra
Gianfranco Sinagra
MGMauro Giacca
Mauro Giacca

1 April 2014 in Cell
Verified
Journal Article
Closed access
BPBao N. Puente
Bao N. Puente
WKWataru Kimura
Wataru Kimura
SMShalini A. Muralidhar
Shalini A. Muralidhar
JMJesung Moon
Jesung Moon
JAJames F. Amatruda
James F. Amatruda
HSHesham Sadek
Hesham Sadek

1 November 2007 in Cell
Verified
Journal Article
Closed access
CFChristian Fischer
Christian Fischer
BJBart Jonckx
Bart Jonckx
Massimiliano MazzoneMassimiliano Mazzone
Massimiliano Mazzone
SZSerena Zacchigna
Serena Zacchigna
SLSonja Loges
Sonja Loges
PCPeter Carmeliet
Peter Carmeliet

16 December 2007 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
CWChangli Wei
Changli Wei
CMClemens C Möller
Clemens C Möller
MAMehmet Mete Altintas
Mehmet Mete Altintas
JLJing Li
Jing Li
KSKarin Schwarz
Karin Schwarz
JRJochen Reiser
Jochen Reiser

8 May 2019 in Nature
Verified
Journal Article
Closed access
PDF file
KGKhatia Gabisonia
Khatia Gabisonia
GPGiulia Prosdocimo
Giulia Prosdocimo
GAGiovanni Donato Aquaro
Giovanni Donato Aquaro
LCLucia Carlucci
Lucia Carlucci
LZLorena Zentilin
Lorena Zentilin
MGMauro Giacca
Mauro Giacca

6 January 2008 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JAJulian Aragones
Julian Aragones
MSMartin Schneider
Martin Schneider
KGKatie Van Geyte
Katie Van Geyte
PFPeter Fraisl
Peter Fraisl
TDTom Dresselaers
Tom Dresselaers
PCPeter Carmeliet
Peter Carmeliet
HIF prolyl hydroxylases (PHD1–3) are oxygen sensors that regulate the stability of the hypoxia-inducible factors (HIFs) in an oxygen-dependent manner. Here, we show that loss of Phd1 lowers oxygen consumption in skeletal muscle by reprogramming glucose metabolism from oxidative to more anaerobic ATP production through activation of a Pparα pathway. This metabolic adaptation to oxygen conservation impairs oxidative muscle performance in healthy conditions, but it provides acute protection of myofibers against lethal ischemia. Hypoxia tolerance is not due to HIF-dependent angiogenesis, erythropoiesis or vasodilation, but rather to reduced generation of oxidative stress, which allows Phd1-deficient myofibers to preserve mitochondrial respiration. Hypoxia tolerance relies primarily on Hif-2α and was not observed in heterozygous Phd2-deficient or homozygous Phd3-deficient mice. Of medical importance, conditional knockdown of Phd1 also rapidly induces hypoxia tolerance. These findings delineate a new role of Phd1 in hypoxia tolerance and offer new treatment perspectives for disorders characterized by oxidative stress.